This course is designed to provide the learner with the most up to date evidence for ICD based therapy. To give an in-depth review of ICD testing and programming as well as device management including complications and follow-up aspects.
Search for "" returned 984 matches
This symposium will address the compelling evidence for aggressive medical and device-based therapies for patients with chronic heart failure. The overall goal is the integration of medical, device, diagnostic and surgical therapies for our patients with chronic heart failure.
DENVER, May 14, 2010 – The Heart Rhythm Society (HRS) has released the first consensus statement for the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting device deactivation. The HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy was written in collaboration with representatives from the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM), the American Heart Association (AHA) and the European Heart Rhythm Association (EHRA).
WASHINGTON, June 1, 2010 — New study findings prove continuing warfarin therapy during pacemaker or defibrillator implantation in patients with moderate to high thromboembolic risk is safe and cost-effective. According to research published in the June edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, cessation of warfarin with bridging anticoagulation resulted in a higher incidence of bleeding complications and a longer hospital stay. In addition, patients with temporarily interrupted anticoagulation suffered from a higher risk of transient ischemic attacks (TIA) than those who continued warfarin therapy.
WASHINGTON, June 14, 2010 — The Heart Rhythm Society announced today that it has become a member of the American Medical Association (AMA) House of Delegates, the policy-making body that makes critical health care decisions and policy changes.
WASHINGTON, July 1, 2010 — New large meta-analysis from five primary prevention randomized implantable cardioverter-defibrillator (ICD) studies shows a smaller impact of Sudden Cardiac Death (SCD) on overall mortality in women. According to research published in the July edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, women in primary prevention ICD trials have the same overall mortality as men, while experiencing significantly less appropriate ICD interventions. With more than 1,600 women, this meta-analysis includes the largest cohort of women to date.
This is a three day course based on the clinical and public health significance of atrial fibrillation
WASHINGTON, August 31, 2010 — Released today, a new study on overall workforce trends in the field of cardiac electrophysiology (EP) reveals an increasing demand for EP professionals as a result of shifting demographic trends, evolving health reform policies and improved procedural outcomes. The comprehensive workforce study published in the September issue of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, found substantial growth in the overall volume and complexity of cardiac procedures performed in the past decade.
WASHINGTON, September 1, 2010 — New research released today is the first to find both anatomical and procedural considerations that can lead to the creation of esophageal ulcerations (ESUL) after radiofrequency ablation of atrial fibrillation (AF). According to a study published in the September issue of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, patients at high-risk for esophageal injury can be identified based on pre-acquired multislice computed tomography. The study is the largest to provide serial endoscopy data on the esophagus after radiofrequency ablation.
This course is designed to provide the learner with the most up-to-date evidence for ICD based therapy. To give an in-depth review of ICD testing and programming as well as device management including complications and follow-up aspects.